Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Finished Goods (2020 - 2026)

SkinHealth Systems has reported Finished Goods over the past 6 years, most recently at $29.5 million for Q4 2025.

  • Quarterly Finished Goods fell 31.62% to $29.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.5 million through Dec 2025, down 31.62% year-over-year, with the annual reading at $29.5 million for FY2025, 31.62% down from the prior year.
  • Finished Goods was $29.5 million for Q4 2025 at SkinHealth Systems, down from $33.1 million in the prior quarter.
  • Over five years, Finished Goods peaked at $82.0 million in Q1 2023 and troughed at $16.4 million in Q3 2021.
  • The 5-year median for Finished Goods is $49.1 million (2023), against an average of $50.2 million.
  • Year-over-year, Finished Goods soared 361.19% in 2022 and then tumbled 42.43% in 2025.
  • A 5-year view of Finished Goods shows it stood at $23.2 million in 2021, then soared by 206.77% to $71.3 million in 2022, then fell by 6.13% to $66.9 million in 2023, then tumbled by 35.6% to $43.1 million in 2024, then tumbled by 31.62% to $29.5 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Finished Goods are $29.5 million (Q4 2025), $33.1 million (Q3 2025), and $36.2 million (Q2 2025).